Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 2Lymphoma 2Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Carcinoma, Hepatocellular 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Doxorubicin 8Vincristine 7Prednisone 7Cyclophosphamide 7Rituximab 5VAP-cyclo protocol 3Radiotherapy 3Methotrexate 3Filgrastim 3Cytarabine 3liposomal amphotericin B 2Vinblastine 2Levofloxacin 2Leucovorin 2Hydrocortisone 2Etoposide 2Early Intervention, Educational 2Drug Therapy 2Dexamethasone 2Darbepoetin alfa 2liposomal doxorubicin 1ferrous sulfate 1ferric gluconate 1belinostat 1Sucrose 1Steroids 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Psychiatric Rehabilitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large-Cell, Anaplastic × Steroids × Clear all
NCT00004112 2024-09-23

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

University of Nebraska

Phase 3 Completed
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡